< Back to companies

Our lungs are the largest organ in our body and are constantly under attack. Over 500MM people globally suffer from a chronic lung disease and with COVID, pollution, smoke and heat many billions more are at risk because they lack the ability to easily monitor and detect the changes in their lung status outside of the clinic. It is vital for all of us to know how healthy our lungs are. Telling.ai answers the question by giving you a detailed lung health report by transforming the world’s smartphones into powerful respiratory monitoring devices that detect the changes in lung function to give patients the information needed to stay healthy and avoid hospitalization by listening to their speech. How does it work? Just speak and we measure the gold standard lung function metrics Telling.ai has developed a unique AI/ML audio processing infrastructure to develop vocal biomarkers. Our solution is available to any person in the world by just speaking into a smartphone, requiring no specialized hardware or sensors, to measure (1) FEV1 and FVC, the gold standard for understanding lung health and (2) Respiratory symptoms. Through our app, we replace the 2 methods to evaluate lung function that have been the same for over a 100 years and require clinical interaction.

Share
Shareable draft
Get Involved in Telling.ai

Company Info

Founded
2018
Website
telling.ai/

Categories

AI / MLPrecision Medicine/Diagnostics

Disease Areas

Technologies

AI/Machine LearningVoice RecognitionBiomarkersMobile Applications
Only accessible to MedStartr community members. Join now

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Sign in to join the conversation.

Sign in to comment
Be the first to comment.

What do you think of Telling.ai?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Your scores and comments are shown with your review on this company's profile.

Get Involved in Telling.ai
💬

Hi, I'm Syggy!

MedStartr's AI healthcare innovation superhero. Just click me for whatever you need! 🥰

💬
Hi, I'm Syggy
your healthcare innovation buddy
💬

Ask Syggy anything

What MedStartr is, how it can help you, events, joining...

You're chatting as a visitor: this conversation stays in this browser, isn't linked to any account, and doesn't move over if you join. Join free